Morfessor 2.0: Python Implementation and Extensions for Morfessor Baseline

Sami Virpioja,Peter Smit,Stig-Arne Grönroos,M. Kurimo

Abstract:

What problem does this paper attempt to address?

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Kai Xing,Ruiqing Fan,Fengyou Wang,Huan Nie,Xi Du,Shuang Gai,Ping Wang,Yulin Yang

DOI: https://doi.org/10.1021/acsami.8b06270

IF: 9.5

2018-01-01

ACS Applied Materials & Interfaces

Abstract:Metal-organic frameworks (MOFs), as drug delivery carriers, with high loading capacity and controllable release behavior can provide a more efficacious therapy in cancer treatments. In our work, a novel biocompatible zinc MOF Zn-cpon-1 with the (3,6)-connected rtl 3D topological network was designed and synthesized via employing ClO4- anion as template. The optically and chemically stable Zn-cpon-1 could be verified as a pH-responsive dual-emission platform and excellent drug delivery carrier with higher 5-fluorouracil (5-FU) (44.75 wt %) loading behavior than 6-mercaptopurine (6-MP) (4.79 wt %) ascribed to the influence of size and shape matching. The multiple interactions between Zn-cpon-1 and 5-FU drug molecules have been discussed and evidenced, which could be quantitatively estimated via the rate constant related to the topological structure. Specially, the gust release behavior of 5-FU@Zn-cpon-1 microcrystal was described and programmed via the Weibull distribution model and could be dual-triggered by the temperature and pH stimulus. This study illustrates that the Zn-cpon-1 without any postmodification performs a favorable potential of being used as biomedical drug delivery alternative carriers in effective drug payload, flexible release administration, and superior dual-stimuli responsiveness.
Effects of Fluorinated Functionalization of Linker on Quercetin Encapsulation, Release and Hela Cell Cytotoxicity of Cu-Based MOFs as Smart pH-Stimuli Nanocarriers

Mozhgan Parsaei,Kamran Akhbari,Emmanuel Tylianakis,George E Froudakis

DOI: https://doi.org/10.1002/chem.202301630

2024-01-02

Chemistry

Abstract:Controlled delivery of target molecules is required in many medical and chemical applications. For such purposes, metal-organic frameworks (MOFs), which possess desirable features such as high porosity, large surface area, and adjustable functionalities, hold great potential as drug carriers. Herein, Quercetin (QU), as an anticancer drug, was loaded on Cu2 (BDC)2 (DABCO) and Cu2 (F4 BDC)2 )DABCO) MOFs (BDC=1,4-benzenedicarboxylate and DABCO=1,4-diazabicyclo[2.2.2]octane). As these Cu-MOFs have a high surface area, an appropriate pore size, and biocompatible ingredients, they can be utilized to deliver QU. The loading efficiency of QU in these MOFs was 49.5 % and 41.3 %, respectively. The drug-loaded compounds displayed sustained drug release over 15 days, remarkably high drug loading capacities and pH-controlled release behavior. The prepared nanostructures were characterized by different characterization technics including FT-IR, PXRD, ZP, TEM, FE-SEM, UV-vis, and BET. In addition, MTT assays were carried out on the HEK-293 and HeLa cell lines to investigate cytotoxicity. Cellular apoptosis analysis was performed to investigate the cell death mechanisms. Grand Canonical Monte Carlo simulations were conducted to analyze the interactions between MOFs and QU. Moreover, the stability of MOFs was also investigated during and after the drug release process. Ultimately, kinetic models of drug release were evaluated.
PEGylated chitosan decorated UiO-66 nanoscale metal–organic frameworks as promising carriers for drug delivery

Yinglu Li,Jing Zhao,Yurui Wang,Tianfu Zhao,Yanan Song,Fei Liang

DOI: https://doi.org/10.1007/s00396-023-05165-3

2023-09-01

Abstract:Nanoscale metal organic frameworks (NMOFs) have become excellent drug carriers for the treatment of cancer or other diseases, due to the advantages of large surface area, high drug loading, tunable structure and easy functionalization, with potential application in the field of drug delivery. In this paper, UiO-66 NMOF was synthesized using terephthalic acid as organic ligand and zirconium chloride as metal salt, and then biocompatible chitosan (CS) and PEGylated chitosan (CS-g-mPEG)-decorated NMOFs as drug carriers were constructed by surface modification, using 5-FU as the drug model. The structures, size and morphology were characterized by IR, XRD, DLS, SEM and TEM respectively. The results showed that when the concentration was 0.0872 M, the molar ratio was 1:1 and the acetic acid amount was 2.9 mL, the average particle size of NMOFs was 145.60 nm and 171.73 nm, respectively. The drug loading capacity and encapsulation rate could reach 15.7% and 52.8%. The in vitro controlled drug release results indicated that the release rate accelerated with increasing temperature and decreasing initial amount, greatly reduced under acidic conditions, and the coating of CS and CS-g-mPEG on the surface of UiO-66 had the effect of controlling drug release, further improved the bioavailability of 5-FU. The decorated UiO-66 NMOFs show excellent biocompatibility as nanodrug carriers and can avoid rapid degradation under gastric acid, which are more suitable for oral drug delivery.

polymer science,chemistry, physical
Innovative chitosan-polyacrylic acid-MoS 2 nanocomposite for enhanced and pH-responsive quercetin delivery

Mehrab Pourmadadi,Hamidreza Abdouss,Amirmohammad Memarzadeh,Majid Abdouss,Sonia Fathi-karkan,Abbas Rahdar,Ana M. Díez-Pascual

DOI: https://doi.org/10.1016/j.mtcomm.2024.108724

IF: 3.8

2024-03-30

Materials Today Communications

Abstract:Cancer remains a global health challenge, with current treatments often leading to adverse side effects. Herein, a pH-sensitive, biocompatible nanocomposite composed of chitosan (CS), polyacrylic acid (PAA), and MoS2 nanosheets, loaded with quercetin (QCT) as a model anticancer drug has been synthesized via the water-oil-water (W/O/W) emulsification method, with the aim to be used for targeted breast cancer treatment. Characterization via Fourier-transform infrared spectroscopy (FT-IR) revealed strong interaction between the polymers via hydrogen bonding, and X-ray diffraction (XRD) showed a reduction in the level of crystallinity upon drug loading. Dynamic light scattering (DLS), zeta potential, and field-emission scanning electron microscopy (FE-SEM) tests revealed that the synthesized nanocarriers were spherical in shape and had a hollow structure, with a mean size of 484 nm and a high zeta potential of +44.3 mV, which confirms their high colloidal stability. The addition of MoS2 nanosheets to the polymeric mixture increased drug loading and encapsulation efficiency to 47% and 89%, respectively. The nanocomposite showed high potential as a pH-responsive drug delivery system, releasing 97% and 68% of QCT in acidic and neutral environments, respectively, over 96 hours. The biological performance was investigated using MTT and flow cytometry assays, which confirmed the efficiency of the nanocomposite for tumor cell removal.

materials science, multidisciplinary
Formulation of double nanoemulsions based on pH-sensitive carboxymethyl cellulose /Starch copper doped carbon quantum dots for quercetin controlled release

Mohammad Najafi,Mehrab Pourmadadi,Majid Abdous,Abbas Rahdar,Sadanand Pandey

DOI: https://doi.org/10.1016/j.molliq.2024.124543

IF: 6

2024-04-01

Journal of Molecular Liquids

Abstract:Nanocomposite Hydrogels are versatile and adaptable in drug delivery, suitable for various administrations. They offer prolonged and regulated drug release which makes them valuable in targeting cancer treatments. This study used the water/oil/water approach to construct a drug nanocarrier. It encapsulated hazelnut oil, serving as a protective and organic membrane that enveloped the nanocarrier and regulated drug release. Quercetin (QC), a potent flavonoid with potential therapeutic applications, faces challenges due to its hydrophobic nature and poor solubility. This approach presents a novel approach to enhance QC's solubility and stability by integrating it with copper carbon quantum dots (Cu-CQDs) into a pH-sensitive carboxymethyl cellulose (CMC) and starch-based hydrogel nanocomposite. This system aims to improve QC delivery while minimizing adverse effects. The nanocomposite exhibited exceptional drug loading and encapsulation efficiencies of 47.00 % ± 0.45 and 86.25 % ± 0.75, respectively, ranking among the top-reported values for similar systems. Fourier-transform infrared spectroscopy (FTIR) was used to examine molecular interactions. X-ray diffraction (XRD) assessment demonstrated the presence of components beneficial for drug solubility enhancement at 2Θ = 17–24°, where QC's crystalline peaks are absent from the CMC/Starch/Cu-CQDs@QC XRD pattern. A particle size of 151.57 ± 37 nm is optimized for selectively targeting cancer cells, minimizing interaction with healthy cells, as revealed through DLS assessment. Morphological characteristics analyzed by FE-SEM support this observation as well. Zeta potential measurement (+38.8 mV) highlights nanocarrier stability. CMC/Starch/Cu-CQDs@QC displayed remarkable cytotoxicity against cancerous cells, reducing U87-MG cell viability to 48 % while maintaining high cell viability (92 %) for normal L929 cells. These results emphasize the promise of this nanocomposite as a QC drug delivery system by indicating improved anticancer efficacy with fewer adverse effects.

chemistry, physical,physics, atomic, molecular & chemical
Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Fenghui Qiao,Zhiqi Jiang,Wen Fang,Jingzhi Sun,Qiaoling Hu

DOI: https://doi.org/10.3390/ijms23137342

IF: 5.6

2022-01-01

International Journal of Molecular Sciences

Abstract:In this work, we report the fabrication and functional demonstration of a kind of dually responsive nanoparticles (NPs) as a potential drug delivery vector. The pH value, corresponding to the acidic microenvironment at the tumor site, and mannitol, to the extracellular trigger agent, were employed as the dually responsive factors. The function of dual responses was achieved by breaking the dynamic covalent bonds between phenylboronic acid (PBA) groups and diols at low pH value (pH 5.0) and/or under the administration of mannitol, which triggered the decomposition of the complex NPs and the concomitant release of anticancer drug of doxorubicin (DOX) loaded inside the NPs. The NPs were composed of modified chitosan (PQCS) with quaternary ammonium and PBA groups on the side chains, heparin (Hep), and poly(vinyl alcohol) (PVA), in which quaternary ammonium groups offer the positive charge for the cell-internalization of NPs, PBA groups serve for the formation of dynamic bonds in responding to pH change and mannitol addition, PVA furnishes the NPs with diol groups for the interaction with PBA groups and the formation of dynamic NPS, and Hep plays the roles of reducing the cytotoxicity of highly positively-charged chitosan and forming of complex NPs for DOX up-loading. A three-step fabrication process of drug-loaded NPs was described, and the characterization results were comprehensively demonstrated. The sustained drug release from the drug-loaded NPs displayed obvious pH and mannitol dependence. More specifically, the cumulative DOX release was increased more than 1.5-fold at pH 5.0 with 20 mg mL−1 mannitol. Furthermore, the nanoparticles were manifested with effective antitumor efficient and apparently enhanced cytotoxicity in response to the acidic pH value and/or mannitol.
In-situ forming Cu-based metal-organic framework in the presence of chitosan-Fe3O4 nanohybrids: A pH-sensitive carrier for controlled release of doxorubicin

Mojtaba Abbasian,Musa Khayyatalimohammadi

DOI: https://doi.org/10.1016/j.ijbiomac.2024.134224

2024-07-27

Abstract:In recent years, stimuli-responsive drug delivery systems based on pH, particularly those developed using bio-derived nanocomposite systems, have gained significant attention. In this work, a novel magnetic carrier was designed based on biopolymeric chitosan and metal-organic framework (MOF) for pH-controlling the release of anticancer drugs. To end this, an in-situ green method was performed to form Cu-based MOF in the presence of a magnetic polysaccharide synthesized by precipitation method toward the construction of CS/Fe3O4/Cu-MOF nanocomposite. The nanocomposite was immersed in an aqueous solution of a model anticancer drug, doxorubicin (DOX), and a higher loading capacity (90.1 ± 0.5 %) was achieved. The in-vitro drug release study showed low release rates in simulated physiological environments (pH 7.4, 37 °C, lower than about 20 %), but higher release rates in tumor tissue conditions (pH 4.5, 41 °C, higher than about 60 %) over 96 h, allowing for sustained and extended delivery of DOX. Additionally, the MTT assay demonstrated that the blank and DOX-loaded CS/Fe3O4/Cu-MOF had good cytocompatibility (over 80 % cell viability) and considerable cytotoxicity (lower than 40 % at 16 μg/mL) toward breast cancer (MCF-7) cell line, respectively. These results indicated that the synthesized nanocomposite with suitable pH-sensitivity has potential as a targeted anticancer agent.
Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution

Reza Abazari,Ali Reza Mahjoub,Alexandra M Z Slawin,Cameron L Carpenter-Warren

DOI: https://doi.org/10.1016/j.ultsonch.2017.12.032

Abstract:In this study, we have reported a biocompatible metal-organic framework (MOF) with ultra-high surface area, which we have shown to have uses as both a cancer treatment delivery system and for environmental applications. Using a sonochemical approach, highly flexible organic H3BTCTB and ditopic 4,4'-BPDC ligands, along with modulators of acetic acid and pyridine were combined to prepare a Zn(II)-based metal-organic framework, DUT-32, [Zn4O(BPDC)(BTCTB)4/3(DEF)39.7(H2O)11.3]. Powder X-ray diffraction (PXRD), field-emission scanning electron microscopy (FE-SEM), and Fourier transform infrared spectroscopy (FTIR) were used to characterize, the particle size, shape, and structure of the DUT-32. To show the effects of shape and size of DUT-32 micro/nano-structures on doxorubicin (DOX) drug release and amoxicillin (AMX) adsorption, time of sonication, initial reagent concentrations, irradiation frequency, and acetic acid to pyridine molar ratios were optimized. The drug-loaded DUT-32 was soaked in simulated body fluid (SBF) and the drug release ratio was monitored through release time to perform in vitro drug release test. A slow and sustained release was observed for DUT-32 micro/nano-structures, having a considerable drug loading capacity. At the pH values 7.4-4.5, various profiles of pH-responsive release were achieved. Also, the prepared DUT-32 micro/nano-structures are found to be biocompatible with PC3 (prostate cancer) and HeLa (cervical cancer) cell lines, when tested by MTT assay. Moreover, DUT-32 micro/nano-structures were studied to show AMX adsorption from aqueous solution. Finally, kinetic studies indicated that AMX adsorption and drug release of DOX via this MOF are of first-order kinetics.
Novel Hydrogel-Based Gelatin/Polyvinyl Alcohol/Titanium Dioxide Nanocomposite as a pH-Responsive Nanocarrier for the Controlled Release of Quercetin in Cancer Therapy

Milad Rahmani,Mehrab Pourmadadi,Sayeh Shakouri,Abbas Rahdar,Ana M. Díez-Pascual,Rahmani, Milad,Pourmadadi, Mehrab,Díez-Pascual, Ana M.

DOI: https://doi.org/10.1007/s12668-024-01411-2

2024-04-26

BioNanoScience

Abstract:Due to the increasing global incidence of cancer and the undesirable side effects of conventional therapies, developing drug delivery systems based on nanomaterials is crucial. In this research, a novel and pH-responsive nanocomposite composed of gelatin/polyvinyl alcohol/titanium dioxide (G/PVA/TiO 2 ) was fabricated through water-in-oil-in-water (W/O/W) emulsification and applied for the delivery of the quercetin (QC) drug. The G/PVA/TiO 2 /QC drug delivery system exhibited 45.7% drug loading and 88.25% encapsulation efficiency due to a high interpenetrating biopolymeric network and the porous structure of TiO 2 . These values are competitive and higher than those reported for other QC drug delivery systems. FT-IR and XRD analyses confirmed the successful synthesis of the nanocomposite and the crystalline nature of its components. FESEM and zeta potential analyses were conducted to examine the morphology and surface charge, respectively. The zeta potential value of 23.6 mV confirmed the good stability of the nanocomposite. Experiments using the dialysis technique revealed higher amount of QC released in a lower pH environment, mimicking a tumor environment, compared to neutral pH, confirming the pH-sensitivity of the G/PVA/TiO 2 /QC nanocomposite. Additionally, it exhibited significant cytotoxicity against MCF-7 cells compared to free QC, as indicated by MTT test results. The flow cytometry assay confirmed that G/PVA/TiO 2 /QC led to a higher apoptotic percentage than free QC, while the free drug showed a higher percentage of necroptotic cells.
Novel Carboxymethyl Cellulose-Based Hydrogel with Core–Shell Fe3O4@SiO2 Nanoparticles for Quercetin Delivery

Mohammad Mahdi Eshaghi,Mehrab Pourmadadi,Abbas Rahdar,Ana M. Díez-Pascual

DOI: https://doi.org/10.3390/ma15248711

IF: 3.4

2022-12-08

Materials

Abstract:A nanocomposite composed of carboxymethyl cellulose (CMC) and core–shell nanoparticles of Fe3O4@SiO2 was prepared as a pH-responsive nanocarrier for quercetin (QC) delivery. The nanoparticles were further entrapped in a water-in-oil-in-water emulsion system for a sustained release profile. The CMC/Fe3O4@SiO2/QC nanoparticles were characterized using dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), a field emission scanning electron microscope (FE-SEM), and a vibrating sample magnetometer (VSM) to obtain insights into their size, stability, functional groups/chemical bonds, crystalline structure, morphology, and magnetic properties, respectively. The entrapment and loading efficiency were slightly improved after the incorporation of Fe3O4@SiO2 NPs within the hydrogel network. The dialysis method was applied for drug release studies. It was found that the amount of QC released increased with the decrease in pH from 7.4 to 5.4, while the sustained-release pattern was preserved. The A549 cell line was chosen to assess the anticancer activity of the CMC/Fe3O4@SiO2/QC nanoemulsion and its components for lung cancer treatment via an MTT assay. The L929 cell line was used in the MTT assay to determine the possible side effects of the nanoemulsion. Moreover, a flow cytometry test was performed to measure the level of apoptosis and necrosis. Based on the obtained results, CMC/Fe3O4@SiO2 can be regarded as a novel promising system for cancer therapy.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,metallurgy & metallurgical engineering
pH-sensitive polyacrylic acid /Fe3O4@SiO2 hydrogel nanocomposite modified with agarose for controlled release of quercetin

Zahra Sadat Mohammadi,Mehrab Pourmadadi,Majid Abdouss,Seyed Hassan Jafari,Abbas Rahdar,Ana M. Díez-Pascual

DOI: https://doi.org/10.1016/j.inoche.2024.112338

IF: 3.428

2024-05-01

Inorganic Chemistry Communications

Abstract:Cancer has consistently been a significant global concern as the leading second cause of death. Improving the performance of chemical methods using a drug delivery system is an alternative approach to cancer treatment. In this study, the delivery of an anti-cancer drug, quercetin (QC), was investigated by placing it in a pH-sensitive hydrogel nanocomposite made of polyacrylic acid (PAA), agarose, and Fe3O4@SiO2 particles. Then, the drug release control was improved by the double emulsion method. Spherical nanoparticles with a smooth surface morphology were observed in the images obtained through field-emission scanning electron microscopy (FESEM), their average size was determined to be 193 nm using dynamic light scattering (DLS) method, and they exhibited a zeta potential of 38 mV. Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) analyses provided evidence of the interactions and chemical bonds in the hydrogel structure. The magnetic properties of the nanocarrier were studied by vibrating-sample magnetometry (VSM). The amount of drug loaded in the PAA-Agarose/Fe3O4@SiO2 increased to 86 %, while the encapsulation efficiency increased to 48 %. Drug release kinetics at physiological (7.4) and acidic (5.4) pH were best fitted with the Korsmeyer-Peppas model, indicating a non-Fickian diffusion mechanism. The U-87 MG glioma cell line was evaluated for toxicity through cytotoxicity assay (MTT) and flow cytometry. A higher percentage of apoptosis was found in PAA-Agarose/Fe3O4@SiO2-QC compared to the free QC system. The findings corroborate that the approach developed herein is highly effective for pH-responsive drug delivery in cancer treatment applications.

chemistry, inorganic & nuclear
Physicochemical and in vitro characterization of Agarose based nanocarriers incorporated with Graphene Quantum Dots/ α-Fe2O3 for targeted drug delivery of Quercetin to liver cancer treatment

Mohammad Najafi,Zahra Khoddam,Mobina Masnavi,Mehrab Pourmadadi,Majid Abdouss

DOI: https://doi.org/10.1016/j.matchemphys.2024.129333

IF: 4.778

2024-05-06

Materials Chemistry and Physics

Abstract:The forefront hydrogel nanocomposite, resulting from the integration of Agarose (Aga), Graphene Quantum Dots (GQDs), and α-Fe2O3, offers a novel approach to pH-responsive drug delivery, specifically tailored for the controlled release of Quercetin (QC), a potent anti-cancer agent. The incorporation of the surfactant Span 80 enhances the unique properties conferred by the integration of α-Fe2O3 into the Aga-modified GQDs hydrogel, resulting in the production of stable nanocarriers that improve QC retention. Thorough analyses utilizing Fourier-transform Infrared Spectroscopy (FT-IR) and X-ray Diffraction (XRD) shed light on the characteristics of the nanocarriers. The presence of nanoparticles within the nanocarriers was confirmed by Dynamic Light Scattering (DLS), revealing a spherical morphology with an average size of approximately 279.04 nm and a polydispersity index (PDI) of 0.24. Measurements of the zeta potential indicated a positive surface charge of about 52.8 mV. In the Aga/GQDs configuration, loading and encapsulation efficiencies reached 35% and 67%, respectively. With the inclusion of α-Fe2O3, improvements were observed, with loading and encapsulation efficiencies reaching 47% and 86.25%, respectively, surpassing previous values. Cellular tests conducted on the HepG2 cell line demonstrated the heightened anticancer efficacy of QC-loaded nanoparticles while assessing potential adverse effects. These results underscore the exciting potential of the nanocarrier as a promising strategy for cancer treatment.

materials science, multidisciplinary
A molecular dynamic simulation study of anticancer agents and UiO-66 as a carrier in drug delivery systems

Tahereh Boroushaki,Mohammad G Dekamin,Seyyed Majid Hashemianzadeh,Mohammad Reza Naimi-Jamal,Mokhtar Ganjali Koli

DOI: https://doi.org/10.1016/j.jmgm.2022.108147

Abstract:Targeted drug delivery systems are effective ways to reduce side effects and enhance the therapeutic efficacy of drugs. Metal-organic frameworks are a new class of porous materials that have been recently used as high-performance nanocarriers in medical applications, such as drug storage and delivery due to high internal surface area, high porosity, low toxicity, high payloads, controlled drug release, their exceptional biocompatibility, and biodegradability. In this study, the loading of anti-cancer drugs Temozolomide, Alendronate, and 5-Fluorouracil inside UiO-66 nanocarrier cavities at the atomic level and different concentrations of the drug were investigated using the molecular dynamics simulation method. Drug interaction energies with UiO-66, two-dimensional density map, and drug mobility in all systems were investigated. It was found that all drugs in higher concentration systems have higher loads than less concentrated systems. Among the drugs used, Temozolomide was located closer to the center of UiO-66 which indicated more negative interaction energy. Therefore, Temozolomide has a more thermodynamic tendency to load inside the UiO-66 cavities than the other studied drugs. Two-dimensional density study showed that all drugs were mainly loaded on metal centers. Temozolomide and Alendronate were loaded on inner centers, although 5-Fluorouracil showed a higher tendency to load on surface metal centers. From studying the mobility of drugs, Temozolomide was less mobile than the other two drugs due to its stronger interaction with UiO-66.
A Multifunctional Aminated UiO-67 Metal-Organic Framework for Enhancing Antitumor Cytotoxicity Through Bimodal Drug Delivery

Weicong Liu,Ying Pan,Yingtao Zhong,Baohong Li,Qiongjie Ding,Hongjia Xu,Yuzhi Qiu,Fei Ren,Bo Li,Mohd Muddassir,Jianqiang Liu

DOI: https://doi.org/10.1016/j.cej.2020.127899

IF: 15.1

2021-01-01

Chemical Engineering Journal

Abstract:Metal-organic frameworks (MOFs) are regarded as promising drug delivery systems (DDSs) for cancer treatment because of their unique porous structures and controlled drug release properties. Herein, we designed and constructed a new multifunctional drug carrier 5-FU/UiO-67-(NH)2-FAM/PMT (FUFP) with 5-FU/UiO-67-(NH)2 as the nanocarriers, FAM as a fluorescence imaging agent and PMT as both FA target and anti-tumor drug (5FAM = 5-carboxyfluorescein, 5-FU = 5-fluorouracil and PMT = pemetrexed). The drug carrier exhibited several functions, including co-loading drugs, targeted delivery and fluorescence imaging to enhance antitumor cytotoxicity for cancer therapy. Through fluorescence imaging and flow cytometry experiments, FUFP presented excellent fluorescence imaging and folate targeted properties to the high expression of folate receptor KB cell compared with low expression A549 cell and moderate expression HeLa cell. Meanwhile, FUFP exhibited superior anti-tumor activity compared single 5-FU and PMT group by the in vitro and vivo experiments. The biocompatibility test of FUFP indicated reasonable biosafety as no evidence of persistent toxicity in vivo was observed. FUFP has unique biological abilities in terms of pH-responsiveness, antitumor efficacy, biocompatibility, and simultaneously release hydrophobic and hydrophilic drug at the tumor site, indicating that this composite is a potential and promising carrier, in which provides a new strategy to co-deliver drugs for MOFs.
Synthesis and Application of a pH-Responsive Functional Metal–Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy

Jingyi Shen,Fangxin Gao,Qian Pan,Zhihui Zong,Lili Liang

DOI: https://doi.org/10.3390/molecules29112643

IF: 4.6

2024-06-05

Molecules

Abstract:Oridonin (Ori) is a naturally existing diterpenoid substance that mainly exists in the Chinese medicinal plant Rabdosia rubescens. It was previously found to possess intriguing biological properties; however, the quick clearance from plasma and limited solubility in water restricts its use as a drug. Several metal–organic frameworks (MOFs), having big surfaces and large pores, have recently been considered promising drug transporters. The zeolitic imidazolate framework-8 (ZIF-8), a form of MOF consisting of 2-methylimidazole with zinc ions, is structurally stable under physiologically neutral conditions, while it can degrade at low pH values such as in tumor cells. Herein, a nanosized drug delivery system, Ori@ZIF-8, was successfully designed for encapsulating and transporting oridonin to the tumor site. The drug loading of the prepared Ori@ZIF-8 was 26.78%, and the particles' mean size was 240.5 nm. In vitro, the release of Ori@ZIF-8 exhibited acid sensitivity, with a slow release under neutral conditions and rapid release of the drug under weakly acidic conditions. According to the in vitro anti-tumor experiments, Ori@ZIF-8 produced higher cytotoxicity than free Ori and induced apoptosis in A549 cancer cells. In conclusion, Ori@ZIF-8 could be a potential pH-responsive carrier to accurately release more oridonins at the tumor site.

chemistry, multidisciplinary,biochemistry & molecular biology
ICG and Sunitinib-loaded NH2-MOFs for Folate-mediated Hepatocellular Carcinoma Dual-modal Therapy

Zhoujing Zhang,Chuang Liu,Ozioma Akakuru,Wenjing Xu,Aiguo Wu,Yewei Zhang

DOI: https://doi.org/10.1007/s40242-021-1206-3

IF: 3.1

2021-06-25

Chemical Research in Chinese Universities

Abstract:This research investigated a novel folic acid(FA)-modified zirconium core metal-organic framework(MOF) Uio-66 as a nanocarrier to deliver indocyanine green(ICG) and Sunitinib to cancer cells for combination therapy. Platinum-loaded Uio-66 nanoparticles(Pu) were synthesized <i>via</i> a one-pot method, followed by the modification with FA on their surfaces. This afforded FPu that enabled subsequent loading of ICG and Sunitinib to achieve dualmodal cancer therapy. Drug loading/release test and singlet oxygen detection were also conducted <i>in vitro</i>, and the nanoparticles showed considerable drug loading efficiency for both ICG and Sunitinib, coupled with a high singlet oxygen generation rate. Specifically, drug loading and encapsulation efficiency of Sunitinib were 2.30% and 72.67%, while those for ICG were 2.87% and 90.28%, respectively. Additionally, cytotoxicity test on HepG2 human hepatocellular carcinoma cancer cell line revealed that the fully functional nanoparticles possess excellent biocompatibility and as such could be further investigated as a potential drug delivery system for effectual carcinoma cancer treatment.

chemistry, multidisciplinary
pH-sensitive ameliorated quercetin delivery using graphene oxide nanocarriers coated with potential anticancer gelatin-polyvinylpyrrolidone nanoemulsion with bitter almond oil

Amin Pirali Najafabadi,Mehrab Pourmadadi,Fatemeh Yazdian,Hamid Rashedi,Abbas Rahdar,Ana M. Díez-Pascual

DOI: https://doi.org/10.1016/j.jddst.2023.104339

IF: 5

2023-04-01

Journal of Drug Delivery Science and Technology

Abstract:The rapid rise of cancer worldwide demonstrates the importance of treatment strategies. In addition to reduce the side effects of conventional treatments, targeted drug delivery systems increase performance and effectiveness. In this research, nanocarriers comprising gelatin (G)-polyvinylpyrrolidone (PVP) coated graphene oxide (GO) were prepared for the first time. The nanocarries were loaded with quercetin (QC) drug and a dual nanoemulsion water/oil/water with bitter almond oil was developed as a membrane around the nanocomposite to control further drug release. XRD, FTIR, FESEM, and DLS analysis confirmed the success of the nanocomposite synthesis and drug loading. The resulting pH-sensitive drug delivery system showed an 87.5% encapsulation efficiency and a 45% drug loading, which are among the highest values reported up to date. The zeta potential of the nanocomposites was about −40 mV, indicating good stability. The release kinetics of the drug followed the Higuchi model, and the presence of a dual nanoemulsion resulted in better drug entrapping efficiency, drug controlled release and long-term release. MTT assay and flow cytometry methods revealed a rate of cancer cell death of 53.14%, which was 36.51% in the apoptotic phase. Taking into account the results obtained herein, PVP-G-GO-QC can be considered as a new promising system for cancer treatment.

pharmacology & pharmacy
Targeted Drug Delivery of Quercetin to Breast Cancer Cells Using a Modified SBA-15 Mesoporous Nanostructure

Mahsa Mirzaei,S. Yousef Ebrahimipour,Maryam Mohamadi,Tayebeh Shamspur

DOI: https://doi.org/10.1007/s10876-024-02582-4

2024-03-13

Journal of Cluster Science

Abstract:Undesired side effects and high hydrophobicity are the main drawbacks of conventional chemotherapeutic drugs. These limitations of cancer therapies prompted the use of nanomedicine. Over the past few years, nano-based drug delivery systems have gained considerable attention for the treatment of cancer. Nanotechnology advances offer a method of delivering anticancer drugs efficiently. In this work, mesoporous silica (SBA-15) has been functionalized with (3-aminopropyl) triethoxysilane (APTES) as a carrier for the anticancer medicine quercetin. Using both van der Waals' force and hydrogen bonds, quercetin could bind to the porous structure. In the next step, the loading of quercetin and carbon quantum dots took place. Then, polyvinylpyrrolidone (PVP) as a capping agent was used to control the release of the drug from the nano-carrier, and finally, folic acid was used to target the drug delivery. The nanocarrier-drug complexes were characterized by EDS, DLS, XRD, BET, FE-SEM, FT-IR, and UV–Vis. Also, drug release tests were performed in in-vitro conditions. Tests performed in buffer solution (pH 5.3) showed the best pharmaceutical availability. For healthy MCF-10A human breast epithelial cells (IC 50 = 53.6 M) than for human breast cancer MCF-7 cells (IC 50 = 13.4 M), formulations made from quercetin are much more toxic. This can be related to the presence of folic acid in the prepared formulation. The surface of cancer cells has a significantly higher number of folate receptors compared with healthy cells, so, the drug-containing formulation accumulates more heavily around cancer cells and has a bigger impact on these cells. The release index of the synthesized nano carrier exhibited the release of quercetin in applied media.

chemistry, inorganic & nuclear
Doxorubicin-Loaded Core–Shell UiO-66@SiO2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment

Daria B. Trushina,Anastasiia Yu. Sapach,Olga A. Burachevskaia,Pavel V. Medvedev,Dmitry N. Khmelenin,Tatiana N. Borodina,Mikhail A. Soldatov,Vera V. Butova

DOI: https://doi.org/10.3390/pharmaceutics14071325

IF: 6.525

2022-06-24

Pharmaceutics

Abstract:Beneficial features of biocompatible high-capacity UiO-66 nanoparticles, mesoporous SiO2, and folate-conjugated pluronic F127 were combined to prepare the core–shell UiO-66@SiO2/F127-FA drug delivery carrier for targeted cellular uptake in cancer treatment. UiO-66 and UiO-66-NH2 nanoparticles with a narrow size and shape distribution were used to form a series of core–shell MOF@SiO2 structures. The duration of silanization was varied to change the thickness of the SiO2 shell, revealing a nonlinear dependence that was attributed to silicon penetration into the porous MOF structure. Doxorubicin encapsulation showed a similar final loading of 5.6 wt % for both uncoated and silica-coated particles, demonstrating the potential of the nanocomposite's application in small molecule delivery. Silica coating improved the colloidal stability of the composites in a number of model physiological media, enabled grafting of target molecules to the surface, and prevented an uncontrolled release of their cargo, with the drawback of decreased overall porosity. Further modification of the particles with the conjugate of pluronic and folic acid was performed to improve the biocompatibility, prolong the blood circulation time, and target the encapsulated drug to the folate-expressing cancer cells. The final DOX-loaded UiO-66@SiO2/F127-FA nanoparticles were subjected to properties characterization and in vitro evaluation, including studies of internalization into cells and antitumor activity. Two cell lines were used: MCF-7 breast cancer cells, which have overexpressed folate receptors on the cell membranes, and RAW 264.7 macrophages without folate overexpression. These findings will provide a potential delivery system for DOX and increase the practical value of MOFs.

pharmacology & pharmacy
Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment

Zahra Gharehdaghi,Rahmatollah Rahimi,Seyed Morteza Naghib,Fatemeh Molaabasi

DOI: https://doi.org/10.1007/s00775-021-01887-3

Abstract:A new multifunctional graphene oxide/Cu (II)-porphyrin MOF nanocomposite (CuG) comprised of Cu-TCPP MOF supported on graphene oxide (GO) nanosheets, has been fabricated by a solvothermal method at low temperature and one-pot process. Cu-TCPP MOF with universal advantages, such as high porosity, nontoxicity, large surface area, and safe biodegradation, combined with GO allows the achievement of an efficient doxorubicin loading (45.7%) and smart pH-responsive release for chemotherapy. More significantly, more than 97% of DOX was released by CuG at pH 5 which was more than that at pH 7.4 (~ 33.5%), while Cu-TCPP MOF displayed DOX release of 68.5% and 49% at pH 5 and 7.4, respectively, illustrating the effect of GO on the smart MOF construction for controllable releasing behavior in vitro. The results of in vitro anticancer experiments demonstrate that the developed nanocarrier exhibited slight or no cytotoxicity on normal cells, while the drug-loaded nanocarrier increased significant cancer cell-killing ability with higher therapeutic efficacy than free DOX, indicating the sustained release behavior of the CuG nanocarrier without any "burst effect". Moreover, the in vivo experiments demonstrated that the CuG-DOX exhibited significantly higher anticancer efficiency compared with free DOX. High anti-cancer therapeutic efficacy of this nanoscale carrier as an efficient pH sensitive agent, has the potential to enter further biomedical investigations. A new smart multifunctional graphene oxide-Cu (II)-porphyrin MOF nanocomposite (CuG) formed of Cu-TCPP MOF and graphene oxide (GO) has successfully fabricated and demonstrated an efficient pH-responsive drug release behavior in cancer therapy without using any targeting ligand.

Morfessor 2.0: Python Implementation and Extensions for Morfessor Baseline

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Effects of Fluorinated Functionalization of Linker on Quercetin Encapsulation, Release and Hela Cell Cytotoxicity of Cu-Based MOFs as Smart pH-Stimuli Nanocarriers

PEGylated chitosan decorated UiO-66 nanoscale metal–organic frameworks as promising carriers for drug delivery

Innovative chitosan-polyacrylic acid-MoS 2 nanocomposite for enhanced and pH-responsive quercetin delivery

Formulation of double nanoemulsions based on pH-sensitive carboxymethyl cellulose /Starch copper doped carbon quantum dots for quercetin controlled release

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

In-situ forming Cu-based metal-organic framework in the presence of chitosan-Fe3O4 nanohybrids: A pH-sensitive carrier for controlled release of doxorubicin

Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution

Novel Hydrogel-Based Gelatin/Polyvinyl Alcohol/Titanium Dioxide Nanocomposite as a pH-Responsive Nanocarrier for the Controlled Release of Quercetin in Cancer Therapy

Novel Carboxymethyl Cellulose-Based Hydrogel with Core–Shell Fe3O4@SiO2 Nanoparticles for Quercetin Delivery

pH-sensitive polyacrylic acid /Fe3O4@SiO2 hydrogel nanocomposite modified with agarose for controlled release of quercetin

Physicochemical and in vitro characterization of Agarose based nanocarriers incorporated with Graphene Quantum Dots/ α-Fe2O3 for targeted drug delivery of Quercetin to liver cancer treatment

A molecular dynamic simulation study of anticancer agents and UiO-66 as a carrier in drug delivery systems

A Multifunctional Aminated UiO-67 Metal-Organic Framework for Enhancing Antitumor Cytotoxicity Through Bimodal Drug Delivery

Synthesis and Application of a pH-Responsive Functional Metal–Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy

ICG and Sunitinib-loaded NH2-MOFs for Folate-mediated Hepatocellular Carcinoma Dual-modal Therapy

pH-sensitive ameliorated quercetin delivery using graphene oxide nanocarriers coated with potential anticancer gelatin-polyvinylpyrrolidone nanoemulsion with bitter almond oil

Targeted Drug Delivery of Quercetin to Breast Cancer Cells Using a Modified SBA-15 Mesoporous Nanostructure

Doxorubicin-Loaded Core–Shell UiO-66@SiO2 Metal–Organic Frameworks for Targeted Cellular Uptake and Cancer Treatment

Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment